IP Library › Granted Patent US 12,540,216
Granted Patent B2
US 12,540,216 · App. 17/547,411 · Granted Feb 3, 2026

Two-component moisture curable thermal interface material for thermal management systems

Inventors: Thanikaivelan Tindivanam Veeraraghavan (Newburgh, IN); Karthikeyan Sengotaiyan (Newburgh, IN); Senthilkumar Veeraraghavan (Newburgh, IN)
Assignee: Uniseal, Inc.
C08G77/08C08L83/04C09J175/04H01L23/3736Y10T428/31663
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,540,216
App. No.
17/547,411
Filed
Dec 10, 2021
Granted
Feb 3, 2026
Kind
B2
Art Unit
1787
USPC
428/447
Abstract

A two-part curable composition which cures to form a thermally conductive cured product, including: (a) a first part including: (1) at least one metal catalytic component for catalyzing the cure reaction; (2) a non-reactive diluent component; (3) a wetting agent component; (4) a filler component; (5) a rheology modifier component; and (6) a pigment component; and (b) a second part including: (1) at least one silane terminated polyurethane polymer; (2) a moisture scavenger; (3) a non-reactive diluent component; (4) a filler component; and (5) a wetting agent component, wherein at least one of the filler components of the first-part and the second-part comprises a thermally conductive filler.

Claims (19)

1 . A two-part curable composition which cures to form a thermally conductive cured product, comprising:

a first part comprising: (1) a metal catalytic component for catalyzing the cure reaction, wherein the metal catalytic component is present from approximately 0.1 percent to approximately 0.5 percent by weight of the total weight of the first part and is

a non-reactive diluent component, wherein the non-reactive diluent component is

a wetting agent component, wherein the wetting agent component is present from approximately 0.1 percent to approximately 5.0 percent by weight of the total weight of the first part and comprises a copolymer with acidic groups; (4) a filler component, wherein the filler component of the first part is present from approximately 40 percent to approximately 95 percent by weight of the total weight of the first part; (5) a rheology modifier component, wherein the rheology modifier component is present from approximately 0.1 percent to approximately 5.0 percent by weight of the total weight of the first part and comprises fumed aluminum oxide; and (6) a pigment component wherein the pigment component of the first part is present from approximately 0.1 percent to approximately 2.0 percent by weight of the total weight of the first part; and

a second part comprising: (1) a silane terminated polyurethane polymer, wherein the silane terminated polyurethane polymer is present from approximately 2 percent to approximately 15 percent by weight of the total weight of the second part and is

wherein X comprises a polyurethane linkage containing at least two polyurethane repeating units; (2) a moisture scavenger, wherein the moisture scavenger is present from approximately 0.1 percent to approximately 5.0 percent by weight of the total weight of the second part and is

a non-reactive diluent component, wherein the non-reactive diluent component is

a filler component, wherein the filler component of the second part is present from approximately 40 percent to approximately 95 percent by weight of the total weight of the second part; and (5) a wetting agent component that is present from approximately 0.1 percent to approximately 5.0 percent by weight of the total weight of the second part, wherein at least one of the filler components of the first part and the second part comprises a thermally conductive filler selected from the group consisting of aluminum oxide, aluminum trihydrate, aluminum nitride, boron nitride, silicon carbide, and graphene nanoplatelet;

wherein the non-reactive diluent component of the first part and the non-reactive diluent component of the second part is present from approximately 2 percent to approximately 15 percent by weight of the total weight of the first part and the second part;

wherein the ratio of the first part to the second part is approximately 1:1 by volume;

wherein the composition gels in between approximately 10 and approximately 240 minutes from the time the first part and the second part are brought together at room temperature;

wherein the first part and second part comprise a pre-cured viscosity of approximately 75 to approximately 1,000 pascal-second at normal temperature and pressure;

wherein the first part and second part comprise a pre-cured density of approximately 2.0 to approximately 3.2 grams per cubic centimeter;

wherein the two-part curable composition cures to form a cured product with a Shore 00 durometer hardness ranging from approximately 50 to approximately 98;

wherein the two-part curable composition cures to form a cured product with a thermal conductivity ranging from approximately 3.0 to approximately 5.0 watts per meter-kelvin;

wherein the two-part curable composition cures to form a cured product that has a flammability rating of V-0 under UL94 standard; and

wherein the two-part curable composition cures to form a cured product that has a minimum dielectric strength of 8 kV/mm.

2 . The two-part curable composition of claim 1 , wherein the thermally conductive filler comprises a combination of: (i) 45% by weight of the two-part curable composition of aluminum oxide having a particle size of 22-85 micrometers; and (ii) 40% by weight of the two-part curable composition of aluminum tri-hydrate having a particle size of 10-60 micrometers; and wherein the composition, after storage for 12 weeks at 80° C. with 80% relative humidity followed by curing, exhibits a thermal conductivity of at least 2.0 W/m·K.

3 . The two-part curable composition of claim 1 , wherein the thermally conductive filler comprises a combination of: (i) 29.5% by weight of the two-part curable composition of boron nitride having a particle size of 35-70 micrometers; (ii) 14% by weight of the two-part curable composition of graphene nanoplatelet having a particle size of 20-150 micrometers; and (iii) 45% by weight of the two-part curable composition of aluminum nitride having a particle size of 50-70 micrometers; wherein the composition, after curing, has a Shore 00 hardness of 96.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 27, 2026
From: VEERARAGHAVAN, THANIKAIVELAN TINDIVANAM; SENGOTAIYAN, KARTHIKEYAN; VEERARAGHAVAN, SENTHIKUMAR
To: UNISEAL, INC.
Reel/Frame 074485/0495 →
Continuity (1)
Related Publication 20230183425A1 · Jun 15, 2023
References Cited (46)
US 7191858B2 · Vanderwees et al. · 2007 [cited by applicant]
US 7841431B2 · Zhou · 2010 [cited by applicant]
US 8117857B2 · Kelty et al. · 2012 [cited by applicant]
US 8322029B2 · Campbell et al. · 2012 [cited by applicant]
US 8431445B2 · Robert · 2013 [cited by applicant]
US 8587945B1 · Hartmann et al. · 2013 [cited by applicant]
US 9048009B2 · Xu et al. · 2015 [cited by applicant]
US 9070958B2 · Obasih et al. · 2015 [cited by applicant]
US 9482142B2 · Paetkau et al. · 2016 [cited by applicant]
US 9593275B2 · Tang et al. · 2017 [cited by applicant]
US 9629283B2 · Soong et al. · 2017 [cited by applicant]
US 10003053B2 · Hartmann et al. · 2018 [cited by applicant]
US 10100195B2 · Okamoto et al. · 2018 [cited by applicant]
US 10246546B2 · Kramer · 2019 [cited by applicant]
US 10270141B2 · Piggott et al. · 2019 [cited by applicant]
US 10301422B2 · Kramer et al. · 2019 [cited by applicant]
US 10356946B2 · Oguma et al. · 2019 [cited by applicant]
US 10407533B2 · Kramer et al. · 2019 [cited by applicant]
US 10476051B2 · Mardall et al. · 2019 [cited by applicant]
US 10607859B2 · Stathakis et al. · 2020 [cited by applicant]
US 11142037B2 · Kim et al. · 2021 [cited by applicant]
US 11207939B2 · Johnston et al. · 2021 [cited by applicant]
US 20020027027A1 · Skala · 2002 [cited by applicant]
US 20050107499A1 · Georgeau · 2005 [cited by examiner]
US 20050241865A1 · Varenne · 2005 [cited by applicant]
US 20100233926A1 · Shin · 2010 [cited by examiner]
US 20120238695A1 · Zander · 2012 [cited by examiner]
US 20130011683A1 · Busman · 2013 [cited by examiner]
US 20130136895A1 · Usui · 2013 [cited by examiner]
US 20150258875A1 · Enomoto et al. · 2015 [cited by applicant]
US 20200157361A1 · Student · 2020 [cited by examiner]
US 20200392275A1 · Thiebes et al. · 2020 [cited by applicant]
US 20210323866A1 · Scardigno et al. · 2021 [cited by applicant]
US 20210395483A1 · Ma · 2021 [cited by examiner]
US 20220073738A1 · Mennecke · 2022 [cited by examiner]
EP 1797155 · 2015 [cited by applicant]
WO WO2009129068 · 2009 [cited by applicant]
WO WO2013186349 · 2013 [cited by applicant]
WO WO2016105915 · 2016 [cited by applicant]
WO WO2017052373 · 2017 [cited by examiner]
WO WO2020165288 · 2020 [cited by applicant]
Martoxide NPL reference, retrieved Dec. 1, 2022. [cited by examiner]
Evonik NPL document (Year: 2017). [cited by examiner]
Apyral NPL reference, retrieved Mar. 22, 2023. [cited by examiner]
BYK NPL document, retrieved Jun. 21, 2024. [cited by examiner]
PCT Written Opinion of the International Searching Authority for International Application No. PCT/US22/051163 mailed Apr. 6, 2023. [cited by applicant]